GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (Q3A4L9)

Analyse AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (Q3A4L9) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q3A4L9
Type
protein
Length
416 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x7c75F0f7d6d136A2b8D4C6C6e9b3D8a697949DF1
Molecule
Serine hydroxymethyltransferase
UniProt
Q3A4L9
Pockets
3 · best druggability 0.50

Structure

1 distinct chain · 51% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine hydroxymethyltransferaseprotein41651% helix, 14% strandQ3A4L9

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11990.500.7735empty
22190.490.7523empty
3510.310.7715empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.